News
-
-
PRESS RELEASE
Nicox Announces First Commercial Sale of ZERVIATE in China by Partner Ocumension, Creating a New Recurrent Revenue Stream
Nicox announces first commercial sale of ZERVIATE in China by partner Ocumension, creating new revenue stream. ZERVIATE, cetirizine ophthalmic solution, treats allergic conjunctivitis in China market -
-
PRESS RELEASE
Nicox Announces Publication of the Adaptive Design Period of the NCX 470 Mont Blanc Phase 3 Trial
Nicox announces the publication of the adaptive design period of the NCX 470 Mont Blanc Phase 3 trial, selecting 0.1% concentration due to better intraocular pressure reduction and safety profile -
-
-
-
-
-